Beijing Tiantan Biological Products Co., Ltd. (SHA: 600161)
China
· Delayed Price · Currency is CNY 23.99
-0.03 (-0.12%)
Oct 10, 2024, 11:30 AM CST
Beijing Tiantan Biological Products Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 5,310 | 5,162 | 4,244 | 4,112 | 3,434 | 3,274 | Upgrade
|
| Other Revenue | 20.41 | 18.38 | 16.86 | - | 11.28 | 8.13 | Upgrade
|
| Revenue | 5,331 | 5,180 | 4,261 | 4,112 | 3,446 | 3,282 | Upgrade
|
| Revenue Growth (YoY) | 5.32% | 21.57% | 3.63% | 19.35% | 4.99% | 11.97% | Upgrade
|
| Cost of Revenue | 2,427 | 2,553 | 2,172 | 2,159 | 1,751 | 1,657 | Upgrade
|
| Gross Profit | 2,904 | 2,628 | 2,089 | 1,954 | 1,695 | 1,625 | Upgrade
|
| Selling, General & Admin | 717.91 | 739.98 | 627.83 | 599.41 | 491.34 | 451.9 | Upgrade
|
| Research & Development | 183.02 | 139.95 | 122.01 | 133.21 | 118.61 | 116.79 | Upgrade
|
| Other Operating Expenses | 53.43 | 42.37 | 44.92 | 47.06 | 36.06 | 34.42 | Upgrade
|
| Operating Expenses | 954.25 | 921.65 | 796.02 | 779.55 | 646.18 | 603.26 | Upgrade
|
| Operating Income | 1,949 | 1,706 | 1,293 | 1,174 | 1,049 | 1,021 | Upgrade
|
| Interest Expense | -3.55 | -3.65 | -2.41 | -3.09 | -2.98 | - | Upgrade
|
| Interest & Investment Income | 101.42 | 92.74 | 90.19 | 80.92 | 35.86 | 23.6 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | 0 | 0.01 | -0 | -0.13 | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.4 | -5.01 | -0.7 | -3.05 | -1.22 | -2.97 | Upgrade
|
| EBT Excluding Unusual Items | 2,041 | 1,790 | 1,380 | 1,249 | 1,080 | 1,042 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.99 | -1.04 | 13.55 | -0.3 | -0.62 | -0.5 | Upgrade
|
| Asset Writedown | -0.22 | -0.22 | -0.03 | -14.28 | -0.06 | -0.48 | Upgrade
|
| Other Unusual Items | 14.21 | 9.65 | 32.63 | 6.77 | 25.18 | 2.5 | Upgrade
|
| Pretax Income | 2,054 | 1,799 | 1,426 | 1,241 | 1,105 | 1,043 | Upgrade
|
| Income Tax Expense | 333.19 | 289.14 | 221.6 | 172.2 | 161.8 | 149.19 | Upgrade
|
| Earnings From Continuing Operations | 1,721 | 1,509 | 1,205 | 1,069 | 943.08 | 894.25 | Upgrade
|
| Minority Interest in Earnings | -451.54 | -399.57 | -323.76 | -308.8 | -304.07 | -283.16 | Upgrade
|
| Net Income | 1,269 | 1,110 | 880.92 | 760.01 | 639.01 | 611.09 | Upgrade
|
| Net Income to Common | 1,269 | 1,110 | 880.92 | 760.01 | 639.01 | 611.09 | Upgrade
|
| Net Income Growth | 19.42% | 25.99% | 15.91% | 18.94% | 4.57% | 19.94% | Upgrade
|
| Shares Outstanding (Basic) | 1,988 | 1,988 | 1,994 | 1,940 | 1,806 | 1,796 | Upgrade
|
| Shares Outstanding (Diluted) | 1,988 | 1,988 | 1,994 | 1,940 | 1,806 | 1,796 | Upgrade
|
| Shares Change (YoY) | 0.45% | -0.32% | 2.79% | 7.41% | 0.59% | -0.04% | Upgrade
|
| EPS (Basic) | 0.64 | 0.56 | 0.44 | 0.39 | 0.35 | 0.34 | Upgrade
|
| EPS (Diluted) | 0.64 | 0.56 | 0.44 | 0.39 | 0.35 | 0.34 | Upgrade
|
| EPS Growth | 18.78% | 26.40% | 12.76% | 10.73% | 3.95% | 19.99% | Upgrade
|
| Free Cash Flow | 1,183 | 1,316 | -228.02 | -151.35 | 93.2 | 116.24 | Upgrade
|
| Free Cash Flow Per Share | 0.60 | 0.66 | -0.11 | -0.08 | 0.05 | 0.06 | Upgrade
|
| Dividend Per Share | 0.125 | 0.125 | 0.042 | 0.069 | 0.069 | 0.035 | Upgrade
|
| Dividend Growth | 199.76% | 199.76% | -39.91% | 0% | 99.43% | 44.40% | Upgrade
|
| Gross Margin | 54.47% | 50.72% | 49.02% | 47.51% | 49.19% | 49.50% | Upgrade
|
| Operating Margin | 36.57% | 32.93% | 30.34% | 28.55% | 30.44% | 31.12% | Upgrade
|
| Profit Margin | 23.81% | 21.42% | 20.67% | 18.48% | 18.55% | 18.62% | Upgrade
|
| Free Cash Flow Margin | 22.19% | 25.40% | -5.35% | -3.68% | 2.71% | 3.54% | Upgrade
|
| EBITDA | 2,224 | 1,951 | 1,452 | 1,313 | 1,182 | 1,150 | Upgrade
|
| EBITDA Margin | 41.71% | 37.67% | 34.07% | 31.92% | 34.29% | 35.03% | Upgrade
|
| D&A For EBITDA | 274.1 | 245.36 | 158.74 | 138.65 | 132.75 | 128.21 | Upgrade
|
| EBIT | 1,949 | 1,706 | 1,293 | 1,174 | 1,049 | 1,021 | Upgrade
|
| EBIT Margin | 36.57% | 32.93% | 30.34% | 28.55% | 30.44% | 31.12% | Upgrade
|
| Effective Tax Rate | 16.22% | 16.08% | 15.54% | 13.88% | 14.64% | 14.30% | Upgrade
|
| Revenue as Reported | 5,331 | 5,180 | 4,261 | 4,112 | 3,446 | 3,282 | Upgrade
|
| Advertising Expenses | - | 1.63 | 5.26 | 6.35 | 7.41 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.